Mirror image phage display - Generating stable therapeutically and diagnostically active peptides with biotechnological means

Journal of Biotechnology

Volumn 161, Issue 2, 2012, Pages 121-125

  Sun, Na ^a   Funke, Susanne Aileen ^a   Willbold, Dieter ^a,b  

^a FORSCHUNGSZENTRUM JÜLICH   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

D enantiomeric peptide; Drug discovery; Mirror image phage display; Pharmaceutical biotechnology

Indexed keywords

ACTIVE PEPTIDES; BIOTECHNOLOGICAL APPROACHES; DRUG DEVELOPMENT; DRUG DISCOVERY; EARLY DIAGNOSIS; IN-VIVO; MIRROR IMAGES; PHAGE DISPLAY; PHARMACEUTICAL BIOTECHNOLOGY;

BIOTECHNOLOGY; ENANTIOMERS; MIRRORS;

PEPTIDES;

3 DEOXY MANNO OCTULOSONIC ACID; AMYLOID BETA PROTEIN; ANTIBIOTIC AGENT; DEXTRO AMINO ACID; PEPTIDE DERIVATIVE; PROTEIN MDM2; PROTEIN P53; SIALIC ACID;

ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; BIOTECHNOLOGY; CELL CYCLE ARREST; DISPLAY SYSTEM; DNA REPAIR; DRUG DELIVERY SYSTEM; ENANTIOMER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MIRROR IMAGE PHAGE DISPLAY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; VIRUS ENTRY;

BIOTECHNOLOGY; CELL SURFACE DISPLAY TECHNIQUES; DRUG DISCOVERY; PEPTIDE HYDROLASES; PEPTIDES; STEREOISOMERISM;

EID: 84864609470     PISSN: 01681656     EISSN: 18734863     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2012.05.019     Document Type: Article

References (52)

1. Bartnik D., Funke S.A., Andrei-Selmer L.C., Bacher M., Dodel R., Willbold D. Differently selected d-enantiomeric peptides act on different Abeta species. Rejuvenation Research 2010, 13:202-205.
2. Brookmeyer R., Gray S., Kawas C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. American Journal of Public Health 1998, 88:1337-1342.
3. Brown C.J., Lain S., Verma C.S., Fersht A.R., Lane D.P. Awakening guardian angels: drugging the p53 pathway. Nature Reviews Cancer 2009, 9:862-873.
4. Cull M.G., Miller J.F., Schatz P.J. Screening for receptor ligands using large libraries of peptides linked to the C-terminus of the lac repressor. Proceedings of the National Academy of Sciences of the United States of America 1992, 89:1865-1869.
5. Dawson P.E., Kent S.B. Synthesis of native proteins by chemical ligation. Annual Review of Biochemistry 2000, 69:923-960.
6. Dawson P.E., Muir T.W., Clark-Lewis I., Kent S.B. Synthesis of proteins by native chemical ligation. Science 1994, 266:776-779.
7. Dennis M.S., Lazarus R.A. Kunitz domain inhibitors of tissue factor-factor VIIa. II. Potent and specific inhibitors by competitive phage selection. Journal of Biological Chemistry 1994, 269:22137-22144.
8. Devlin J.J., Panganiban L.C., Devlin P.E. Random peptide libraries: a source of specific protein binding molecules. Science 1990, 249:404-406.
9. Dintzis H.M., Symer D.E., Dintzis R.Z., Zawadzke L.E., Berg J.M. A comparison of the immunogenicity of a pair of enantiomeric proteins. Proteins 1993, 16:306-308.
10. Doorbar J., Winter G. Isolation of a peptide antagonist to the thrombin receptor using phage display. Journal of Molecular Biology 1994, 244:361-369.
11. Eckert D.M., Kim P.S. Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:11187-11192.
12. Eckert D.M., Malashkevich V.N., Hong L.H., Carr P.A., Kim P.S. Inhibiting HIV-1 entry: discovery of d-peptide inhibitors that target the gp41 coiled-coil pocket. Cell 1999, 99:103-115.
13. Funke S.A., van Groen T., Kadish I., Bartnik D., Nagel-Steger L., Brener O., Sehl T., Batra-Safferling R., Moriscot C., Schoehn G., Horn A.H.C., Muller-Schiffmann A., Korth C., Sticht H., Willbold D. Oral treatment with the d-enantiomeric peptide D3 Improves the pathology and behavior of Alzheimer's disease transgenic mice. ACS Chemical Neuroscience 2010, 1:639-648.
14. Funke S.A., Willbold D. Peptides for therapy and diagnosis of Alzheimer's disease. Current Pharmaceutical Design 2012, 18:755-767.
15. Gallop M.A., Barrett R.W., Dower W.J., Fodor S.P., Gordon E.M. Applications of combinatorial technologies to drug discovery. 1. Background and peptide combinatorial libraries. Journal of Medicinal Chemistry 1994, 37:1233-1251.
16. Gulyas B., Spenger C., Beliczai Z., Gulya K., Kasa P., Jahan M., Jia Z., Weber U., Pfeifer A., Muhs A., Willbold D., Halldin C. Distribution and binding of (18)F-labeled and (125)I-labeled analogues of ACI-80, a prospective molecular imaging biomarker of disease: a whole hemisphere post mortem autoradiography study in human brains obtained from Alzheimer's disease patients. Neurochemistry international 2012, 60:153-162.
17. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
18. Inestrosa N., De Ferrari G.V., Garrido J.L., Alvarez A., Olivares G.H., Barria M.I., Bronfman M., Chacon M.A. Wnt signaling involvement in beta-amyloid-dependent neurodegeneration. Neurochemistry International 2002, 41:341-344.
19. Jahan M., Nag S., Krasikova R., Weber U., Muhs A., Pfeifer A., Spenger C., Willbold D., Gulyas B., Halldin C. Fluorine-18 labeling of three novel d-peptides by conjugation with N-succinimidyl-4-[(18)F]fluorobenzoate and preliminary examination by postmortem whole-hemisphere human brain autoradiography. Nuclear Medicine and Biology 2012, 39:315-323.
20. Kent S.B. Total chemical synthesis of proteins. Chemical Society Reviews 2009, 38:338-351.
21. Klussmann S., Nolte A., Bald R., Erdmann V.A., Furste J.P. Mirror-image RNA that binds d-adenosine. Nature Biotechnology 1996, 14:1112-1115.
22. Koivunen E., Gay D.A., Ruoslahti E. Selection of peptides binding to the alpha 5 beta 1 integrin from phage display library. Journal of Biological Chemistry 1993, 268:20205-20210.
23. Kozlov I.A., Mao S., Xu Y., Huang X., Lee L., Sears P.S., Gao C., Coyle A.R., Janda K.D., Wong C.H. Synthesis of solid-supported mirror-image sugars: a novel method for selecting receptors for cellular-surface carbohydrates. Chembiochem 2001, 2:741-746.
24. Liu H., Funke S.A., Willbold D. Transport of Alzheimer disease amyloid-beta-binding d-amino acid peptides across an in vitro blood-brain barrier model. Rejuvenation Research 2010, 13:210-213.
25. Liu M., Li C., Pazgier M., Mao Y., Lv Y., Gu B., Wei G., Yuan W., Zhan C., Lu W.Y., Lu W. d-peptide inhibitors of the p53-MDM2 interaction for targeted molecular therapy of malignant neoplasms. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:14321-14326.
26. Liu M., Pazgier M., Li C., Yuan W., Lu W. A left-handed solution to peptide inhibition of the p53-MDM2 interaction. Angewandte Chemie International Edition in English 2010, 49:3649-3652.
27. Majumder P., Gomes K.N., Ulrich H. Aptamers: from bench side research towards patented molecules with therapeutic applications. Expert Opinion on Therapeutic Patents 2009, 19:1603-1613.
28. Martens C.L., Cwirla S.E., Lee R.Y., Whitehorn E., Chen E.Y., Bakker A., Martin E.L., Wagstrom C., Gopalan P., Smith C.W., et al. Peptides which bind to E-selectin and block neutrophil adhesion. Journal of Biological Chemistry 1995, 270:21129-21136.
29. Martins C.P., Brown-Swigart L., Evan G.I. Modeling the therapeutic efficacy of p53 restoration in tumors. Cell 2006, 127:1323-1334.
30. Mattheakis L.C., Bhatt R.R., Dower W.J. An in vitro polysome display system for identifying ligands from very large peptide libraries. Proceedings of the National Academy of Sciences of the United States of America 1994, 91:9022-9026.
31. Milton R.C., Milton S.C., Kent S.B. Total chemical synthesis of a d-enzyme: the enantiomers of HIV-1 protease show reciprocal chiral substrate specificity. Science 1992, 256:1445-1448.
32. Muller-Schiffmann A., Marz-Berberich J., Andreyeva A., Ronicke R., Bartnik D., Brener O., Kutzsche J., Horn A.H., Hellmert M., Polkowska J., Gottmann K., Reymann K.G., Funke S.A., Nagel-Steger L., Moriscot C., Schoehn G., Sticht H., Willbold D., Schrader T., Korth C. Combining independent drug classes into superior, synergistically acting hybrid molecules. Angewandte Chemie International Edition in English 2010, 49:8743-8746.
33. Nolte A., Klussmann S., Bald R., Erdmann V.A., Furste J.P. Mirror-design of l-oligonucleotide ligands binding to l-arginine. Nature Biotechnology 1996, 14:1116-1119.
34. Pappenheimer J.R., Dahl C.E., Karnovsky M.L., Maggio J.E. Intestinal absorption and excretion of octapeptides composed of D amino acids. Proceedings of the National Academy of Sciences of the United States of America 1994, 91:1942-1945.
35. Pappenheimer J.R., Karnovsky M.L., Maggio J.E. Absorption and excretion of undegradable peptides: role of lipid solubility and net charge. Journal of Pharmacology and Experimental Therapeutics 1997, 280:292-300.
36. Pazgier M., Liu M., Zou G., Yuan W., Li C., Li J., Monbo J., Zella D., Tarasov S.G., Lu W. Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:4665-4670.
37. Sadowski M., Pankiewicz J., Scholtzova H., Ripellino J.A., Li Y., Schmidt S.D., Mathews P.M., Fryer J.D., Holtzman D.M., Sigurdsson E.M., Wisniewski T. A synthetic peptide blocking the apolipoprotein E/beta-amyloid binding mitigates beta-amyloid toxicity and fibril formation in vitro and reduces beta-amyloid plaques in transgenic mice. American Journal of Pathology 2004, 165:937-948.
38. Schumacher T.N., Mayr L.M., Minor D.L., Milhollen M.A., Burgess M.W., Kim P.S. Identification of d-peptide ligands through mirror-image phage display. Science 1996, 271:1854-1857.
39. Schwarzman A.L., Tsiper M., Gregori L., Goldgaber D., Frakowiak J., Mazur-Kolecka B., Taraskina A., Pchelina S., Vitek M.P. Selection of peptides binding to the amyloid b-protein reveals potential inhibitors of amyloid formation. Amyloid 2005, 12:199-209.
40. Scott J.K., Smith G.P. Searching for peptide ligands with an epitope library. Science 1990, 249:386-390.
41. Soto C. Plaque busters: strategies to inhibit amyloid formation in Alzheimer's disease. Molecular Medicine Today 1999, 5:343-350.
42. Ulrich H. RNA aptamers: from basic science towards therapy. Handbook of Experimental Pharmacology 2006, 305-326.
43. van Groen T., Kadish I., Wiesehan K., Funke S.A., Willbold D. In vitro and in vivo staining characteristics of small, fluorescent, Abeta42-binding d-enantiomeric peptides in transgenic AD mouse models. ChemMedChem 2009, 4:276-282.
44. van Groen T., Wiesehan K., Funke S.A., Kadish I., Nagel-Steger L., Willbold D. Reduction of Alzheimer's disease amyloid plaque load in transgenic mice by D3, A d-enantiomeric peptide identified by mirror image phage display. ChemMedChem 2008, 3:1848-1852.
45. Ventura A., Kirsch D.G., McLaughlin M.E., Tuveson D.A., Grimm J., Lintault L., Newman J., Reczek E.E., Weissleder R., Jacks T. Restoration of p53 function leads to tumour regression in vivo. Nature 2007, 445:661-665.
46. Vogelstein B., Lane D., Levine A.J. Surfing the p53 network. Nature 2000, 408:307-310.
47. Welch B.D., Francis J.N., Redman J.S., Paul S., Weinstock M.T., Reeves J.D., Lie Y.S., Whitby F.G., Eckert D.M., Hill C.P., Root M.J., Kay M.S. Design of a potent d-peptide HIV-1 entry inhibitor with a strong barrier to resistance. Journal of Virology 2010, 84:11235-11244.
48. Welch B.D., VanDemark A.P., Heroux A., Hill C.P., Kay M.S. Potent d-peptide inhibitors of HIV-1 entry. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:16828-16833.
49. Wiesehan K., Buder K., Linke R.P., Patt S., Stoldt M., Unger E., Schmitt B., Bucci E., Willbold D. Selection of d-amino-acid peptides that bind to Alzheimer's disease amyloid peptide abeta1-42 by mirror image phage display. Chembiochem 2003, 4:748-753.
50. Wiesehan K., Stohr J., Nagel-Steger L., van Groen T., Riesner D., Willbold D. Inhibition of cytotoxicity and amyloid fibril formation by a d-amino acid peptide that specifically binds to Alzheimer's disease amyloid peptide. Protein Engineering Design & Selection 2008, 21:241-246.
51. Wiesehan K., Willbold D. Mirror-image phage display: aiming at the mirror. Chembiochem 2003, 811-815.
52. Xue W., Zender L., Miething C., Dickins R.A., Hernando E., Krizhanovsky V., Cordon-Cardo C., Lowe S.W. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 2007, 445:656-660.